## RJF: Raymond James Financial, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.22 indicates fundamental undervaluation. Quality metrics strong (ROE 18%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($156.27)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Raymond James Investment Management names new president**
- Source: Pensions & Investments | 20251215T160831 | Neutral | Relevance: 100%
- Jeff Ringdahl has been appointed as the new president of Raymond James Investment Management. The announcement was made on December 15, 2025, at 11:22 AM EST. This move is part of the "People on the Move" section by Pensions & Investments.

**2. Raymond James IM names Jeff Ringdahl as new president**
- Source: International Adviser | 20251215T150444 | Bullish | Relevance: 100%
- Raymond James Investment Management (IM) has appointed Jeff Ringdahl as its new president, effective January 5th. Ringdahl will oversee the growth strategy and direction of the business, which manages around $118.5 billion in assets. He brings over 25 years of experience, including previous roles as president and COO at Summit Trail Advisors and CEO, president, and COO at American Beacon Partners.

**3. Raymond James Investment Management Names Jeff Ringdahl as President**
- Source: GlobeNewswire | 20251215T090200 | Bullish | Relevance: 100%
- Raymond James Investment Management has appointed Jeff Ringdahl as its new President, effective January 5th. Ringdahl, who brings over 25 years of experience, will be responsible for leading the company's growth strategy and overseeing key initiatives. He previously served as president and COO of Summit Trail Advisors and held senior positions at American Beacon Partners.

**4. Stance Capital LLC Purchases New Holdings in Raymond James Financial, Inc. $RJF**
- Source: MarketBeat | 20251214T124548 | Somewhat-Bullish | Relevance: 100%
- Stance Capital LLC significantly increased its investment in Raymond James Financial, Inc. by acquiring 16,355 shares valued at approximately $2.5 million during the second quarter, making it their 17th largest holding. Other institutional investors like Princeton Global Asset Management LLC and TD Private Client Wealth LLC also boosted their stakes. The article details analyst ratings, price targets, and the financial performance of Raymond James Financial, including its recent dividend increase.

**5. Raymond Jamesâ€™ Reilly sells shares worth $21.3 million**
- Source: Investing.com | 20251216T012415 | Neutral | Relevance: 100%
- Paul C. Reilly, Executive Chair of Raymond James Financial Inc. (NASDAQ:RJF), sold 130,687 shares for approximately $21.3 million and an additional 96,697 shares for $15.8 million to cover tax liabilities. Despite these sales, Reilly still holds a significant stake in the company, which continues to grow through an increased dividend, expanded buyback program, and strategic partnerships like the one with Bank Midwest. The company also received analyst coverage from UBS and Morgan Stanley, with both firms recognizing its strong financial position and brand.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | B of A Securiti | $196 | $194 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | B of A Securiti | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 15 ($0.00M) |
| Sells | 19 ($0.23M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 11.1% (-1.4%)
- Blackrock Inc.: 7.4% (-2.9%)
- JPMORGAN CHASE & CO: 5.9% (+108.2%)
- Primecap Management : 4.9% (-3.7%)
- Wellington Managemen: 4.6% (-5.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.22 suggests fair value with growth premium. Quality metrics strong (margin 15%). Institutional flow bullish (1 buying vs 9 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.5B |
| Beta | 1.01 |
| 52W Range | $117.57 - $177.66 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.22 |
| Forward P/E | 12.1 |
| Current P/E | 13.5 |
| YoY Growth | 11.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 improving modestly (+0.9% over 5 days). Below STRENGTH zone by 1.2pp (needs >4.0% for momentum thesis). MRS_5 at 0.5% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.89), confirming momentum. RSI neutral at 55. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.82% (CS: 57) | Neutral |
| RSI_14 | 54.6 | Neutral |
| MACD Histogram | 0.89 | Bullish |
| vs SMA20 | 1.025x | Above |
| vs SMA50 | 1.013x | Above |
| vs SMA200 | 1.050x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $162.83
- **Stop Loss:** $156.27 (4.0% risk)
- **Target:** $175.95 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 182
- **Position Value:** $29,635.06
- **Portfolio %:** 29.64%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-28 (Est: $2.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.83 | $3.11 | +10.0% |
| 2025Q2 | $2.36 | $2.18 | -7.5% |
| 2025Q1 | $2.44 | $2.42 | -0.7% |
| 2024Q4 | $2.69 | $2.93 | +8.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*